http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007070278-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9df90d7822cc480ce12c480f4089e229 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 |
| filingDate | 2005-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2adbc7fcf2ae72ddfaa5d91d88f3c8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c7db89ec83903c6dd35d0ada8d56ccc |
| publicationDate | 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007070278-A |
| titleOfInvention | Medicine |
| abstract | PROBLEM TO BE SOLVED: To provide a drug made for the purpose of elucidating physiological characteristics of an oxoline compound and developing a new and useful use thereof. [Solution] General formula (R 1 is a hydrocarbon group, hydrocarbon oxy group, heteroaryl group, ferrocenyl group, silyl group, substituted silyl group or arylseleno group, R 2 and R 3 are hydrogen atoms or hydrocarbon groups, R 4 and R 5 are Hydrocarbon group or hydrocarbon oxy group, n is 0 or 1) It is set as the pharmaceutical which contains the oxoline compound represented by these as an active ingredient. [Selection figure] None |
| priorityDate | 2005-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.